Mobile Menu

Search Results

Search results for: Oncology

Interview with CRUK: Promises and pitfalls of precision medicine clinical trials

Ahead of our virtual panel discussion on the promises and pitfalls of precision medicine trials: now and in the future […]

Representative sampling method improves the genetic testing for cancer treatment

A wholistic tumour sampling method developed by researchers from The Francis Crick Institute, Roche, and The Royal Marsden NHS Foundation […]

Opinion: Precision medicine will be driven by diagnostic technologies

Earlier this week, Stephane Budel wrote an article about the role diagnostic technologies will play in the future of precision medicine. […]

Genomics against COVID-19: A summary

Last week, we asked the genomics community how they were shifting their focus to help fight the novel coronavirus. We […]

Interview with Dr Luigi Grassi, Informatics Scientist, AstraZeneca

I’m Luigi Grassi and I’m an Informatics Scientist at AstraZeneca. I’m responsible for designing and performing bioinformatical analyses of the […]

Transforming R&D with Data

With the cost of developing a drug doubling every 9 years, the pharma business model will soon become largely unsustainable. […]

CRUK funds development of POC blood-based brain cancer test

Cancer Research UK (CRUK) has funded a project run by a team of researchers at the University of Bristol to […]

Coming of age? How to translate generation genome into clinical practice

Karen Lighting Jones, Head of Future Place at Roche. Back in 2016, Dame Sally Davies concluded her Chief Medical Officer annual report by saying “Genomics is not tomorrow, it’s here today. I believe genomic services should be available to more patients, whilst being a cost-effective service in the NHS”.